Subject: healthy young adult subjects | haematological and biochemical reference intervals | pre-and post-intervention safety analysis | clinical trials | Research Paper | candidate vaccines
This was a retrospective study to determine the validity of institutional reference intervals for interpreting biochemistry and hematology results in healthy adults in the context of clinical trials of preventive vaccines. An example population of 974 healthy adults par... View more
1. Friedberg RC, Souers R, Wagar EA, Stankovic AK, Valenstein PN; College of American Pathologists. The origin of reference intervals. Arch Pathol Lab Med 2007; 131:348-57; PMID:17516737
2. Shine B. Use of routine clinical laboratory data to define reference intervals. Ann Clin Biochem 2008; 45:467- 75; PMID:18753418; http://dx.doi.org/10.1258/ acb.2008.008028
3. Lacher DA, Hughes JP, Carroll MD. Biological variation of laboratory analytes based on the 1999- 2002 National Health and Nutrition Examination Survey. Natl Health Stat Report 2010; 2010:1-7; PMID:20540274
4. Kariv R, Leshno M, Beth-Or A, Strul H, Blendis L, Kokia E, et al. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int 2006; 26:445-50; PMID:16629648; http://dx.doi. org/10.1111/j.1478-3231.2006.01197.x
5. Bain BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol 1996; 49:664-6; PMID:8881919; http://dx.doi. org/10.1136/jcp.49.8.664
6. Horowitz GL, Altaie S, Boyd JC, Ceriotti F, Garg U, Horn P, et al. Defining, establishing, and verifying reference intervals in the clinical laboratory: Approved guideline. 3rd ed. Clinical and Laboratory Standards Institute (CLSI), 2008.
7. Richmond PC, Nissen MD, Marshall HS, Lambert SB, Roberton D, Gruber WC, et al. A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine 2012; 30:6163-74; PMID:22871351; http:// dx.doi.org/10.1016/j.vaccine.2012.07.065
8. Riveau G, Deplanque D, Remoué F, Schacht AM, Vodougnon H, Capron M, et al. Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl Trop Dis 2012; 6:e1704; PMID:22802974; http://dx.doi. org/10.1371/journal.pntd.0001704
9. US Department of Health and Human Services Food and Drug Administration. Guidance for Industry. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. 2007.
10. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 2004; 351:1548-63; PMID:15470219